APH.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:35):

Stats
Today's Volume	254 137
Average Volume	1.02M
Market Cap	188.87M
EPS	£0 ( 2024-04-09 )
Last Dividend	£1.184 ( 2023-06-22 )
Next Dividend	£0 ( N/A )
P/E	-34.95
ATR14	£0.108 (0.31%)

Volume Correlation

Long: 0.09 (neutral)

Short: 0.07 (neutral)

Signal:(55.851) Neutral

Alliance Pharma PLC Correlation

10 Most Positive Correlations
RCN.L	0.919
XUEB.L	0.905
BIRG.L	0.905
AIBG.L	0.902
FOG.L	0.896
EBQ.L	0.885
NUM.L	0.883
DTY.L	0.881
EMAU.L	0.871
CLIN.L	0.867

10 Most Negative Correlations
TEP.L	-0.906
3NIS.L	-0.896
LNGA.L	-0.885
GFIN.L	-0.884
INHC.L	-0.882
PTRO.L	-0.882
GIF.L	-0.882
BIDS.L	-0.878
ECHO.L	-0.872
PUR.L	-0.871

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alliance Pharma PLC Correlation - Currency/Commodity

-0.15
( neutral )

-0.13
( neutral )

0.00
( neutral )

-0.28
( neutral )

0.01
( neutral )

-0.08
( neutral )

Alliance Pharma PLC Financials

Annual	2022
Revenue:	£167.42M
Gross Profit:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2022
Revenue:	£167.42M
Gross Profit:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2021
Revenue:	£163.21M
Gross Profit:	£109.45M (67.06 %)
EPS:	£0.0137

FY	2020
Revenue:	£129.80M
Gross Profit:	£82.82M (63.80 %)
EPS:	£0.0154

Financial Reports:

No articles found.

Alliance Pharma PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0.592 (N/A)	£0 (N/A)	£1.184 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Alliance Pharma PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 6.61 - average (87.25%) | Divividend Growth Potential Score: 3.43 - Decrease likely (31.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.0700	2009-12-02
Last Dividend	£1.184	2023-06-22
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	£15.63	--
Avg. Dividend % Per Year	1.27%	--
Score	3.29	--
Div. Sustainability Score	6.61
Div.Growth Potential Score	3.43
Div. Directional Score	5.02	--

Next Divdend (Est)
(2024-10-14)

£1.255 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.29

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2009	£0.0700	2.33%
2010	£0.400	1.48%
2011	£0.650	2.11%
2012	£0.775	2.51%
2013	£0.853	2.67%
2014	£0.938	2.32%
2015	£1.033	2.79%
2016	£1.137	2.65%
2017	£1.250	2.75%
2018	£1.375	2.04%
2019	£1.513	2.30%
2020	£0.536	0.63%
2021	£2.20	2.50%
2022	£1.720	1.57%
2023	£1.184	2.17%
2024	£0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUPR.L	Dividend Knight	2023-07-13	Quarterly	8	3.25%
KNOS.L	Ex Dividend Knight	2023-09-28	Semi-Annually	10	0.61%
CGT.L	Dividend Junior	2023-06-01	Annually	44	0.66%
QXT.L	Ex Dividend Junior	2023-07-27	Sporadic	11	0.46%
GOOD.L	Dividend Knight	2023-09-28	Annually	13	0.55%
ARC.L	Ex Dividend Knight	2023-10-05	Annually	8	1.10%
TPFG.L	Dividend Knight	2023-09-21	Annually	11	3.16%
MCT.L	Dividend King	2023-07-13	Quarterly	11	195.14%
CTEC.L	Dividend Knight	2023-08-17	Semi-Annually	8	1.46%
RUR.L	Dividend Knight	2023-06-22	Sporadic	20	10.67%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0415	1.500	-0.830	-1.245	[0 - 0.5]
returnOnAssetsTTM	-0.0137	1.200	-0.458	-0.550	[0 - 0.3]
returnOnEquityTTM	-0.0250	1.500	-1.389	-2.08	[0.1 - 1]
payoutRatioTTM	-1.315	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.931	0.800	5.35	4.28	[1 - 3]
quickRatioTTM	1.333	0.800	6.86	5.49	[0.8 - 2.5]
cashRatioTTM	0.533	1.500	8.15	10.00	[0.2 - 2]
debtRatioTTM	0.242	-1.500	5.96	-8.94	[0 - 0.6]
interestCoverageTTM	3.05	1.000	9.98	9.98	[3 - 30]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0397	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.449	-1.500	8.20	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.516	1.000	4.74	4.74	[0.2 - 0.8]
operatingProfitMarginTTM	0.144	1.000	9.13	9.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.174	1.000	-0.143	-0.143	[0.2 - 2]
assetTurnoverTTM	0.331	0.800	-1.127	-0.901	[0.5 - 2]
Total Score				6.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-26.70	1.000	-2.80	0	[1 - 100]
returnOnEquityTTM	-0.0250	2.50	-0.893	-2.08	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0397	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	3.39	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	-1.315	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	92.42	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.128	1.000	9.31	0	[0.1 - 0.5]
Total Score				3.43

Alliance Pharma PLC

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.